pre-IPO PHARMA

COMPANY OVERVIEW

Batu Biologics is an immuno-oncology company focused on the development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Immunology
  • Oncology

  • WEBSITE

    https://batubiologics.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    May 3, 2019

    Dr. Thomas Ichim Appointed President and Chief Executive Officer of Batu Biologics Inc.


    Oct 17, 2018

    Batu Biologics Recruits Dr. Vijay Mahant as the Vice President of Precision Oncology to Oversee the Personalization of ValloVax Immunogenicity


    Sep 24, 2018

    Batu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog


    Aug 20, 2018

    Batu Biologics Identifies Gene Types Associated with Response to ValloVax


    Jul 26, 2018

    Batu Biologics Files Patent on Patient Selection for Right to Try Law


    For More Press Releases


    Google Analytics Alternative